to enjoy learning and progressing in cardiometabolic practice
11th ACC 2025: HOST-BR Trial
12th ACC 2025: RIVAWAR Trial
6th ACC 2025: FRESH-UP Study
14th ACC 2025: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y
15th ACC 2025: DapaTAVI Trial
9th ACC 2025: ALIGN-AR Trial
10th ACC 2025: FAIR-HF2 Trial
16th ACC 2025: MI and Cardiovascular Risks Associated with Cannabis Use
8th ACC 2025: BHF PROTECT-TAVI Trial
2nd ACC 2025: ADVANCE-HTN Trial
1st ACC 2025: SMART-CHOICE 3 Trial
Antithrombotic Therapy in CCS
Antithrombotic Therapy in ACS
Antithrombotic Therapy in VTE
Antithrombotic Therapy in AF
POCUS Basic Echocardiography
17th AHA 2024: VANISH2 Trial
14th AHA 2024: PHARM-HF A&F Trial
15th AHA 2024: TOPSPIN Trial
Preventive Cardiology
Preventive Cardiology
16th AHA 2024: ALPACAR-360 Trial
13th AHA 2024: ENDEAVOR Trial
10th AHA 2024: BROOKLYN Trial
6th AHA 2024: ATTR Cardiomyopathy
5th AHA 2024: REALIZE-K Trial
Case Discussion 123: Borderline QT Interval
4th AHA 2024: AI image-recognition for heart images
3rd AHA 2024: BRAIN-AF Trial
Case Discussion 120: VTE prophylaxis
Case Discussion 119: CAC Score
21st H&H Academy Session
21st H&H Academy Session
Case Discussion 118: Omalizumab in CVD
1st AHA 2024: OASIS 9 Trial
Online Grand Round: Approach to NSTE-ACS